trending Market Intelligence /marketintelligence/en/news-insights/trending/uvkxys-ji6xe0ultypfzow2 content esgSubNav
In This List

Stryker completes $662M Entellus Medical acquisition

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Stryker completes $662M Entellus Medical acquisition

Stryker Corp. completed its $662 million acquisition of medical device maker Entellus Medical Inc.

Stryker expects the merger to be dilutive to its 2018 adjusted earnings by approximately 4 cents per share and accretive thereafter.

The deal complements Stryker's existing portfolio of surgical devices related to ear, nose and throat, or ENT.